Mckesson Aspirin Tablet, Film Coated
NDC Package 68599-1311-3
Package Information
Mckesson Aspirin (aspirin) tablets is usestemporarily relievesheadachemuscle painminor pain of arthritispain and fever of coldstoothachemenstrual pain. This formulation utilizes a tablet, film coated delivery system. Marketed by Mckesson Medical-surgical, this product is identified by NDC 68599-1311 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 212033 - aspirin 325 MG Oral Tablet
- RxCUI: 212033 - ASA 325 MG Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 68599 - Mckesson Medical-surgical
- 68599-1311 - Mckesson Aspirin
- 68599-1311-3 - 250 PACKET in 1 BOX / 2 TABLET, FILM COATED in 1 PACKET
- 68599-1311 - Mckesson Aspirin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68599-1311-3 identifies a specific commercial package of 250 packet in 1 box / 2 tablet, film coated in 1 packet of Mckesson Aspirin, a human over the counter drug labeled by Mckesson Medical-surgical. This tablet, film coated is formulated for oral use and contains aspirin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mckesson Medical-surgical on May 02, 2022. The current certification is valid through December 31, 2027.
How is this Mckesson Medical-surgical product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68599131103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.